Public-Private Partnerships Can Boost Innovation, Affordability Of Women’s Health Products
GlobalPost: Partnering to protect women from HIV
Zeda Rosenberg, CEO of the International Partnership for Microbicides (IPM), and Paul Stoffels, Johnson & Johnson’s chief scientific officer and chair of Janssen Pharmaceutical Companies of Johnson & Johnson
“…A new public-private partnership agreement announced last week between our organizations — the International Partnership for Microbicides (IPM), a nonprofit product developer, and the Janssen Pharmaceutical Companies of Johnson & Johnson, a major research-based pharmaceutical company — could help … ensure women have the tools to protect themselves from [HIV] infection. … Partnerships like ours are powerful solutions to the challenges of developing health products for women…” (5/15).